Simon Schwartz Navarro Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools. Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services LinkedIn Twitter Orcid Email Simon Schwartz Navarro LinkedIn Twitter Orcid Email Institutions of which they are part Main researcher Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT) Vall Hebron Institut de Recerca Cap de Secció Bioquímica Cross-departmental services Senior scientist and advisor with specific interest in Nanomedicine and Advanced Therapies applied to unmet clinical needs. I am also acting as strategy coordinator to facilitate programs and initiatives that foster innovation in new treatments and diagnostic tools.
Currently acting as Strategy director of biobanking and bioresources at Vall d'hebron Campus. President of the European Society of Nanomedicine and Executive Board member of the International Society of Nanomedicine. Former director general of the Blood and Tissue Banc of Catalonia. Former director of CIBBIM-Nanomedicine. Former scientific associate director of CIBER-BBN and coordinator of technology transfer. Former director assistance of translational research at VHIR. H-index of 40, with more that 115 high impact publications and 17 transferred patents. Co-founder of 3 biotech companies (i.e, Bsure Medical ltd). Science Advisor of the European Nanomedicine Characterization Laboratory (EU-NCL). Member of the editorial Board of Precision Nanomedicine, J. Nanotechnology and of J. of Nanotheranostics. Former editorial Board member of Eur. J. Nanomedicine and Nanomedicine-NBM.
Projects Anàlisi de l'expressió i funció del hCD 300f/CLM1 murí en cèl·lules de micròglia i identificació del lligant del mateix immunoreceptor en oligodentrocits primaris on s'estudiarà la seva possible funció IP: Simon Schwartz Navarro Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 4188 Reference: 2010 BE1 00133 Duration: 01/05/2011 - 31/07/2011 Development of nanomedicines for enzymatic replacement therapy in Fabry disease IP: Simon Schwartz Navarro Collaborators: Development of nanomedicines for enzymatic replacement therapy in Fabry disease Funding agency: Fundació La Marató de TV3 Funding: 214925 Reference: MARATV3/2010/101230 Duration: 03/02/2011 - 31/12/2014 NANOSTEM-Acción complementaria IP: Simon Schwartz Navarro Collaborators: - Funding agency: Ministerio de Ciencia e Innovación-MICINN Funding: 3000 Reference: SAF2009-08592-E Duration: 01/11/2009 - 30/04/2010 Targetting Combined Therapy to Cancer Stem Cells (Nanoquest) IP: Simon Schwartz Navarro Collaborators: - Funding agency: Agència Gestió Ajuts Universitaris i de Recerca Funding: 4680.44 Reference: 2009LID2-C-20 Duration: 01/01/2010 - 20/01/2010 Pagination First page « Previous page ‹ … Page 5 Page 6 Current page 7 Page 8 Page 9 … Next page › Last page »
